Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (561-570 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|July 18, 2022
Conditional relative survival among patients with chronic lymphocytic leukaemia: A population-based study in the NetherlandsLina van der Straten, Mark-David Levin, Otto Visser, et al.
Ejhaem|July 18, 2022
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio groupFrancesca Fazio, Luca Franceschini, Valeria Tomarchio, et al.
Ejhaem|July 18, 2022
Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndromeYandong Shen, Luke Coyle, Ian Kerridge, et al.
Ejhaem|August 22, 2025
Disease Activity After Switching From Eculizumab to Ravulizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria: Real World Data From Denmark and FinlandAnders Rønneholt-Frederiksen, Dennis Lund Hansen, Vuokko Nummi, et al.
Ejhaem|August 8, 2022
Sickle cell disease patients with COVID-19 in Guadeloupe: Surprisingly favorable outcomesEmmanuelle Bernit, Marc Romana, Scylia Alexis-Fardini, et al.
Ejhaem|February 23, 2023
Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cellsMaximilian Kiefer, Lorenz Thurner, Theresa Bock, et al.
Ejhaem|February 23, 2023
Global longitudinal strain is superior to ejection fraction for long-term follow-up after allogeneic hematopoietic stem cell transplantationMarika Watanabe, Kimikazu Yakushijin, Hidekazu Tanaka, et al.
Ejhaem|February 23, 2023
Biallelic <i>TET2</i> mutations and canonical <i>ASXL1</i> mutations are frequent and cooccur in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): An institutional experience and review of literatureXi Zhang, Eric D Hsi, Genevieve M Crane, et al.
Ejhaem|February 23, 2023
Patient reported outcome measures in Waldenström macroglobulinaemia: A real-world data analysis from the WMUK Rory Morrison RegistryJahanzaib Khwaja, Encarl Uppal, Sotirios Bristogiannis, et al.
Ejhaem|February 23, 2023
Germline <i>RUNX1</i> variants in paediatric patients in a French specialised centreCécile Liu, Paola Ballerini, Guillaume Nguyen, et al.
Pageof 93

Showing results (561-570 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|July 18, 2022
Conditional relative survival among patients with chronic lymphocytic leukaemia: A population-based study in the NetherlandsLina van der Straten, Mark-David Levin, Otto Visser, et al.
Ejhaem|July 18, 2022
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio groupFrancesca Fazio, Luca Franceschini, Valeria Tomarchio, et al.
Ejhaem|July 18, 2022
Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndromeYandong Shen, Luke Coyle, Ian Kerridge, et al.
Ejhaem|August 22, 2025
Disease Activity After Switching From Eculizumab to Ravulizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria: Real World Data From Denmark and FinlandAnders Rønneholt-Frederiksen, Dennis Lund Hansen, Vuokko Nummi, et al.
Ejhaem|August 8, 2022
Sickle cell disease patients with COVID-19 in Guadeloupe: Surprisingly favorable outcomesEmmanuelle Bernit, Marc Romana, Scylia Alexis-Fardini, et al.
Ejhaem|February 23, 2023
Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cellsMaximilian Kiefer, Lorenz Thurner, Theresa Bock, et al.
Ejhaem|February 23, 2023
Global longitudinal strain is superior to ejection fraction for long-term follow-up after allogeneic hematopoietic stem cell transplantationMarika Watanabe, Kimikazu Yakushijin, Hidekazu Tanaka, et al.
Ejhaem|February 23, 2023
Biallelic <i>TET2</i> mutations and canonical <i>ASXL1</i> mutations are frequent and cooccur in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): An institutional experience and review of literatureXi Zhang, Eric D Hsi, Genevieve M Crane, et al.
Ejhaem|February 23, 2023
Patient reported outcome measures in Waldenström macroglobulinaemia: A real-world data analysis from the WMUK Rory Morrison RegistryJahanzaib Khwaja, Encarl Uppal, Sotirios Bristogiannis, et al.
Ejhaem|February 23, 2023
Germline <i>RUNX1</i> variants in paediatric patients in a French specialised centreCécile Liu, Paola Ballerini, Guillaume Nguyen, et al.
Pageof 93